The global medical exoskeleton market accounted to US$ 96.7 Mn in 2018 and is expected to grow at a CAGR of 29.4% during the forecast period 2019 – 2027
The medical exoskeleton market is an emerging in nature with consisting of the good and countable number of players, having considerable revenue in the market. Most of the companies operating in the global medical exoskeleton market are offers medical exoskeleton for the lower and upper limb. The medical exoskeleton offered by the companies offers several benefits that assist disabled people, elderly people to carry out their daily routine and mobility. The medical exoskeleton also assist people working in various industrial sectors.
The most notable medical exoskeleton market participants are ReWalk Robotics, Ekso Bionics Holdings, Inc., Parker Hannifin Corporation (Indego), CYBERDYNE, INC., Bionik Laboratories Corp., Hocoma AG, Tyromotion GmbH, B-Temia Inc., US Bionics Inc. and Gogoa Mobility Robots among the others have occupied a considerable share of the market owing to their product offerings to the companies.
Market leaders are involved in organic and inorganic growth strategies in the medical exoskeleton market . For instance, the companies have maximized their growth with several organic strategies to enhance the market value and position in the market. The organic developments in the medical exoskeleton market were maximum among the development in the medical exoskeleton.
The medical exoskeleton market has experienced several organic strategies such as product launch, product approval and others activities that has resulted positively for the growth of the market. The companies have also conducted inorganic strategies such as agreements, partnership and others that has enhance the product portfolio.
Below is the list of the inorganic and organic strategies done by the players operating in the medical exoskeleton market:
|January, 2019||BIONIK Laboratories Corp has announced the launch of its new robotic system InMotion ARM/HAND. The systems are used for clinical rehabilitation of stroke survivors and people having mobility impairments.||North America|
|June, 2019||ReWalk Robotics announced that it has received U.S. Food and Drug Administration approval for its ReStore soft exo-suit system. The approval has helped in the sales of the product to the rehabilitation centers across the United States.||North America|
|May, 2019||Ekso Bionics Holdings, Inc. announced that in Singapore at National University Health System (NUHS) three EksoGT exoskeletons has been adopted for clinical study.||North America|
|December, 2018||BIONIK Laboratories Corp has announced signing of an agreement for multiple years with Kindred Hospital Rehabilitation Services for its InMotion Arm robotic systems.||North America|
|December, 2017||Ekso Bionics Holdings, Inc Partnered with HASOMED GmbH to Launch Functional Electrical Stimulation (FES) for the EksoGT Exoskeleton interface capability||North America|
|September, 2016||Hocomo AG merges with DIH International, the merger was done for providing the solution of entire rehabilitation continuum.||North America|